Diagnostics News and Research

RSS

New, simple device to detect lung pathogens causing pneumonia

Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year.

19 Feb 2011

Novavax announces final safety, immunogenicity results from H1N1 VLP vaccine at WHO meeting

Novavax, a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th World Health Organization Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials.

19 Feb 2011

PreXion launches new 3D Elite Cone Beam Imaging System with CLEARimage Scanning Technology

PreXion, Inc., the leader in high quality 3D Cone Beam Computed Tomography (CBCT) Imaging systems for dentistry, today announced that it has launched and started shipping a new 3D cone beam imaging product, the PreXion3D Elite with CLEARimage™ Scanning Technology.

19 Feb 2011

Abbott increases company's quarterly dividend 9% to 48 cents per share

The board of directors of Abbott today increased the company's quarterly common dividend 9 percent to 48 cents per share.

19 Feb 2011

U.S. scientists assess progress of dengue vaccine at 3-day summit in Puerto Rico

During a meeting in Puerto Rico on Thursday to discuss recent progress towards fighting dengue, researchers voiced optimism over advances in the development of vaccines to prevent the spread of the virus, "which kills 25,000 people every year," Agence France-Presse reports. The three-day summit was hosted by the NIH, CDC and PAHO, according to the news service.

19 Feb 2011

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has signed a licensing agreement with Biocare Medical, a biotechnology company based in Concord, Calif., for the exclusive worldwide sales and distribution rights for the immunohistochemistry of an antibody designed to detect tumor prevalence in prostate cancer patients.

18 Feb 2011

Safeguard Scientifics' 2010 partner company aggregate revenue exceeds $400 million

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for 2010 exceeded $400 million, beating previously issued guidance of $360 million to $385 million.

18 Feb 2011

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.

18 Feb 2011

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

"A rise in global funding for research into neglected diseases needs to be matched by a continued focus on delivering practical new ways to curb sickness in the developing world," according to the third annual report by the Global Funding of Innovation for Neglected Diseases released on Wednesday, Reuters reports.

18 Feb 2011

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Endo Pharmaceuticals and Bioniche Life Sciences Inc. today announced plans for peer-reviewed presentation of interim efficacy and safety results from the first Phase III trial of the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™ or EN3348.

18 Feb 2011

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Genomic Health, Inc. today announced the presentation of two studies at the American Society of Clinical Oncology® (ASCO®) Genitourinary (GU) Cancer Symposium, including complete results from its prostate cancer gene identification study, which identified 295 genes strongly associated with clinical recurrence following radical prostatectomy with great consistency across multiple tumor samples examined in each patient.

17 Feb 2011

Poll: 73% of New Jersey people think investment on global health research is important to state's economy

Despite the unpredictable economy, nearly three-quarters of New Jersey residents think spending money on research to improve health globally is important to jobs and incomes in the state, according to a new statewide poll commissioned by Research!America.

17 Feb 2011

USAID Administrator discusses global health programs at NIH event

USAID Administrator Rajiv Shah on Tuesday delivered a speech at the National Institutes of Health (NIH) where he reaffirmed President Barack Obama's commitment to the 6-year $63 billion Global Health Initiative (GHI) and discussed the USAID's role in bolstering U.S. global health programs, CIDRAP News reports. During his speech, Shah emphasized the administration's focus on structuring global health programs to be more cost efficient.

17 Feb 2011

ACEA Biosciences receives new U. S. Patent for chemical compound screening

ACEA Biosciences, a pioneer in the development of high-performance microelectronic systems for cell-based assays, diagnostics, and pharmaceutical research, is pleased to report the issuance of a new U. S. Patent for chemical compound screening, with important applications in the development of new pharmaceutical products.

17 Feb 2011

U.S. Patent Office issues Notice of Allowance to Biomoda's CyPath assay for cancer detection

Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent application on a quantitative method for scoring cells labeled with the CyPath assay to determine whether cells are dysplastic or carcinomic by measuring the photon emission rate.

17 Feb 2011

Sonablate HIFU device is now available in Brazil to treat prostate cancer

USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.

17 Feb 2011

BD announces addition of new flow cytometry system for rapid microbial enumeration, detection

Industrial microbiologists now have a new tool that was designed specifically to help quality control laboratories rapidly screen raw materials, as well as in-process and finished goods, for the presence of microorganisms that can threaten product quality.

17 Feb 2011

Endo Pharmaceuticals, Bioniche announce first patient enrollment in Urocidin second Phase III trial

Endo Pharmaceuticals and Bioniche Life Sciences Inc., today announced enrollment of the first patient in the second Phase III clinical trial of Urocidin.

16 Feb 2011

BG Medicine receives US patent for galectin-3 testing to detect heart failure

BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.

16 Feb 2011

IMGM Labs purchases Fluidigm Access Array system to use in re-sequencing applications

IMGM Laboratories GmbH has purchased a Fluidigm Access Array System to use in its development and validation of targeted re-sequencing applications services.

16 Feb 2011

Diagnostics News and Research

New, simple device to detect lung pathogens causing pneumonia

Novavax announces final safety, immunogenicity results from H1N1 VLP vaccine at WHO meeting

PreXion launches new 3D Elite Cone Beam Imaging System with CLEARimage Scanning Technology

Abbott increases company's quarterly dividend 9% to 48 cents per share

U.S. scientists assess progress of dengue vaccine at 3-day summit in Puerto Rico

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

Safeguard Scientifics' 2010 partner company aggregate revenue exceeds $400 million

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Poll: 73% of New Jersey people think investment on global health research is important to state's economy

USAID Administrator discusses global health programs at NIH event

ACEA Biosciences receives new U. S. Patent for chemical compound screening

U.S. Patent Office issues Notice of Allowance to Biomoda's CyPath assay for cancer detection

Sonablate HIFU device is now available in Brazil to treat prostate cancer

BD announces addition of new flow cytometry system for rapid microbial enumeration, detection

Endo Pharmaceuticals, Bioniche announce first patient enrollment in Urocidin second Phase III trial

BG Medicine receives US patent for galectin-3 testing to detect heart failure

IMGM Labs purchases Fluidigm Access Array system to use in re-sequencing applications

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News